← Back to Search

Corticosteroid

Hydrocortisone 20 MG for Alcohol Consumption

Phase < 1
Waitlist Available
Led By Elizabeth V Goldfarb, PhD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 90 minutes
Awards & highlights

Study Summary

This study is evaluating whether hydrocortisone may have positive impacts for individuals with alcohol use disorder.

Eligible Conditions
  • Alcohol Consumption
  • Alcohol Use Disorder
  • Episodic Memory
  • Long-term Memory

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 90 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 90 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Affect memory
Changes fMRI signal
Context memory
+1 more
Secondary outcome measures
Affect - Negative
Affect - Positive
Alcohol motivation
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: hydrocortisoneExperimental Treatment1 Intervention
Participants receive hydrocortisone (20mg)
Group II: placeboPlacebo Group1 Intervention
Participants receive placebo.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hydrocortisone 20 MG
2021
Completed Early Phase 1
~30

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,847 Previous Clinical Trials
2,736,501 Total Patients Enrolled
Elizabeth V Goldfarb, PhDPrincipal InvestigatorYale University
1 Previous Clinical Trials
100 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Neuroimaging Mechanisms by Which Memory and Glucocorticoids Promote Risky Drinking
2021. "Neuroimaging Mechanisms by Which Memory and Glucocorticoids Promote Risky Drinking". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04896489.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top